Buscador de publicacions

Publicacions

  • Villarroya-Terrade J, Redondo-Angulo I, Iglesias R, Giralt M, Villarroya-Gombau F and Planavila A.

    Sirt1 mediates the effects of a short-term high-fat diet on the heart.

    JOURNAL OF NUTRITIONAL BIOCHEMISTRY . 26(11): 1328-1337. Nº de cites: 8

    [doi:10.1016/j.jnutbio.2015.07.029]

  • Gavaldà-Navarro A, Hondares E, Giralt M, Mampel T, Iglesias R and Villarroya-Gombau F.

    Fibroblast growth factor 21 in breast milk controls neonatal intestine function.

    SCIENTIFIC REPORTS . 5: 13717-13717. Nº de cites: 19

    [doi:10.1038/srep13717]

  • Cereijo R, Villarroya-Terrade J and Villarroya-Gombau F.

    Non-sympathetic control of brown adipose tissue.

    International journal of obesity supplements . 5(Suppl 1): .

    [doi:10.1038/ijosup.2015.10]

  • Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, Escoté X, Gómez-Serrano M, Peral B, Salvadó L, Fernández-Veledo S, Casals N, Vazquez M, Villarroya-Gombau F, Vendrell JJ, Serra D and Herrero L.

    Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation.

    AM J PHYSIOL-ENDOC M . 308(9): . Nº de cites: 101

    [doi:10.1152/ajpendo.00362.2014]

  • Sánchez-Infantes D, Gallego-Escuredo J, Díaz-Silva M, Aragonès G, Sebastiani G, López-Bermejo A, de Zegher F, Domingo P, Villarroya-Gombau F and Ibañez-Toda L.

    Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations

    INTERNATIONAL JOURNAL OF OBESITY . 39(5): 742-746. Nº de cites: 21

    [doi:10.1038/ijo.2015.2]

  • Planavila A, Redondo-Angulo I, Ribas F, Garrabou G, Casademont J, Giralt M and Villarroya-Gombau F.

    Fibroblast growth factor 21 protects the heart from oxidative stress.

    CARDIOVASC RES . 106(1): 19-31. Nº de cites: 165

    [doi:10.1093/cvr/cvu263]

  • Cereijo R, Giralt M and Villarroya-Gombau F.

    Thermogenic brown and beige/brite adipogenesis in humans.

    ANN MED . 47(2): 169-177. Nº de cites: 59

    [doi:10.3109/07853890.2014.952328]

  • Sheedfar F, Vermeer M, Pazienza V, Villarroya-Terrade J, Rappa F, Cappello F, Mazzoccoli G, Villarroya-Gombau F, van der Molen H, Hofker MH, Koonen DP and Vinciguerra M.

    Genetic ablation of macrohistone H2A1 leads to increased leanness, glucose tolerance and energy expenditure in mice fed a high-fat diet.

    INTERNATIONAL JOURNAL OF OBESITY . 39(2): 331-338. Nº de cites: 19

    [doi:10.1038/ijo.2014.91]

  • Domingo P, Lamarca MK, Gallego-Escuredo JM, Torres F, Domingo JC, Villarroya-Terrade J, Gutierrez Mdel M, Mateo MG, Vidal F, Villarroya-Gombau F and Giralt M.

    Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients.

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 70(6): 1825-1832. Nº de cites: 6

    [doi:10.1093/jac/dkv027]

  • Guzmán-Ruiz R, Ortega F, Rodríguez A, Vázquez-Martínez R, Díaz-Ruiz A, Garcia-Navarro S, Giralt M, Garcia-Rios A, Cobo-Padilla D, Tinahones FJ, López-Miranda J, Villarroya-Gombau F, Frühbeck G, Fernández-Real JM and Malagón MM.

    Alarmin high-mobility group B1 (HMGB1) is regulated in human adipocytes in insulin resistance and influences insulin secretion in ß-cells.

    INTERNATIONAL JOURNAL OF OBESITY . 38(12): 1545-1554. Nº de cites: 60

    [doi:10.1038/ijo.2014.36]